Share
Journal Information
Original article
Interstitial lung disease related to rheumatoid arthritis: Evolution after treatment
La enfermedad pulmonar intersticial relacionada con la artritis reumatoide: evolución después del tratamiento
Jorge Rojas-Serranoa,
, Edilzar González-Velásquezb, Mayra Mejíac, Alain Sánchez-Rodríguezd, Guillermo Carrilloc
Corresponding author
a Servicio Clínico de Enfermedades Intersticiales del Pulmón, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico
b Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, México DF, Mexico
c Servicio Clínico de Enfermedades Intersticiales del Pulmón, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, México DF, Mexico
d Universidad Veracruzana, Campus Minatitlan, Veracruz, Mexico
Article
This article is available in English
Interstitial Lung Disease Related to Rheumatoid Arthritis: Evolution After Treatment
Jorge Rojas-Serrano, Edilzar González-Velásquez, Mayra Mejía, Alain Sánchez-Rodríguez, Guillermo Carrillo
10.1016/j.reumae.2011.12.001Reumatol Clin. 2012;8:68-71
Special content about COVID-19
- Spontaneous pneumomediastinum: An extra muscular manifestation of anti-MDA5 dermatomyositis. Report of 2 cases
- The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam
- Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment
- The “autoimmune/inflammatory syndrome induced by adjuvants” (ASIA) after COVID-19 infection: A case report
Publish in
Reumatología Clínica